This week’s episode of “WisBusiness: The Podcast” features a chat with JangoBio CEO Craig Atwood, who discusses the Madison-based biotech company’s current efforts to develop a therapy to stop the clock on certain age-related diseases.
By using stem cell therapy to target the hormone-regulating cells that degrade, the company hopes to counter the effects of aging associated with imbalanced hormones. Listen to the podcast here.
JangoBio is one of the presenters during the TCIN Presentations at the 2017 Early Stage Symposium. Learn more about the conference here.